MX2015006852A - Ensayos para detectar autoanticuerpos neutralizantes para terapia biologica. - Google Patents
Ensayos para detectar autoanticuerpos neutralizantes para terapia biologica.Info
- Publication number
- MX2015006852A MX2015006852A MX2015006852A MX2015006852A MX2015006852A MX 2015006852 A MX2015006852 A MX 2015006852A MX 2015006852 A MX2015006852 A MX 2015006852A MX 2015006852 A MX2015006852 A MX 2015006852A MX 2015006852 A MX2015006852 A MX 2015006852A
- Authority
- MX
- Mexico
- Prior art keywords
- neutralizing
- therapy
- present
- biologic
- assays
- Prior art date
Links
- 230000003472 neutralizing effect Effects 0.000 title abstract 6
- 238000001815 biotherapy Methods 0.000 title abstract 4
- 238000003556 assay Methods 0.000 title abstract 2
- 239000003814 drug Substances 0.000 abstract 4
- 229940079593 drug Drugs 0.000 abstract 3
- 238000012544 monitoring process Methods 0.000 abstract 2
- 238000002560 therapeutic procedure Methods 0.000 abstract 2
- 239000003124 biologic agent Substances 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 230000009260 cross reactivity Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 230000001988 toxicity Effects 0.000 abstract 1
- 231100000419 toxicity Toxicity 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/52—Assays involving cytokines
- G01N2333/525—Tumor necrosis factor [TNF]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Rehabilitation Therapy (AREA)
- Rheumatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261732251P | 2012-11-30 | 2012-11-30 | |
| US13/802,117 US20130266963A1 (en) | 2011-07-06 | 2013-03-13 | Assay for detecting neutralizing autoantibodies to biologic therapy |
| PCT/IB2013/060458 WO2014083520A2 (en) | 2012-11-30 | 2013-11-27 | Assays for detecting neutralizing autoantibodies to biologic therapy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2015006852A true MX2015006852A (es) | 2015-09-16 |
Family
ID=50828561
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2015006852A MX2015006852A (es) | 2012-11-30 | 2013-11-27 | Ensayos para detectar autoanticuerpos neutralizantes para terapia biologica. |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP2926136A2 (enExample) |
| JP (1) | JP2016502091A (enExample) |
| KR (1) | KR20150088890A (enExample) |
| CN (1) | CN105074461A (enExample) |
| AU (1) | AU2013350817A1 (enExample) |
| BR (1) | BR112015012482A2 (enExample) |
| CA (1) | CA2892766A1 (enExample) |
| HK (1) | HK1215969A1 (enExample) |
| IL (1) | IL238995A0 (enExample) |
| MX (1) | MX2015006852A (enExample) |
| RU (1) | RU2015125739A (enExample) |
| SG (2) | SG11201504097PA (enExample) |
| WO (1) | WO2014083520A2 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2778454C (en) | 2009-10-26 | 2021-03-02 | Prometheus Laboratories Inc. | Assays for the detection of anti-tnf drugs and autoantibodies |
| JP5960707B2 (ja) | 2010-10-18 | 2016-08-02 | ネステク ソシエテ アノニム | 抗薬物抗体アイソタイプを決定するための方法 |
| KR20140047628A (ko) | 2011-07-06 | 2014-04-22 | 네스텍 소시에테아노님 | Ｔｎｆ알파로의 생물학적 치료요법에 대한 중화 자가항체의 검출을 위한 검정 |
| JP2018500553A (ja) | 2014-12-05 | 2018-01-11 | ネステク ソシエテ アノニム | 患者試料における生物製剤の検出のための間接的均一移動度シフトアッセイ |
| EP3243078A1 (en) | 2015-01-09 | 2017-11-15 | Atonomics A/S | A universal assay for determining the quantity of tnf inhibitory drugs and their corresponding anti-drug-antibodies |
| JP2019522199A (ja) | 2016-07-08 | 2019-08-08 | アトノミックス アクティーゼルスカブ | 試料中の治療用モノクローナル抗体及びそれらの対応する抗薬物抗体の量を確定するためのユニバーサルアッセイ |
| CN110546506B (zh) * | 2017-03-31 | 2023-04-04 | 埃博灵克斯股份有限公司 | 改进的免疫原性测定法 |
| WO2021136773A1 (en) * | 2020-01-02 | 2021-07-08 | F. Hoffmann-La Roche Ag | Ada-response specification assay |
| CN111024958B (zh) * | 2020-03-11 | 2020-06-23 | 同昕生物技术（北京）有限公司 | 用于检测单抗药物和抗单抗药物抗体的试剂及其应用 |
| CN112730846B (zh) * | 2020-12-18 | 2023-12-15 | 安渡生物医药(杭州)有限公司 | 一种用于小鼠血样检测免疫复合物的方法 |
| CN114047343B (zh) * | 2022-01-13 | 2022-05-31 | 美迪西普亚医药科技(上海)有限公司 | 双耐受型抗IgE单抗药物的免疫原性分析试剂盒及其使用方法和应用 |
| CN117871856A (zh) * | 2023-12-15 | 2024-04-12 | 首都医科大学附属北京地坛医院 | 可溶性因子在无症状神经梅毒检测中的应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2778454C (en) * | 2009-10-26 | 2021-03-02 | Prometheus Laboratories Inc. | Assays for the detection of anti-tnf drugs and autoantibodies |
| AU2011247610A1 (en) * | 2010-04-29 | 2012-12-13 | Therading Sa | Methods for detecting antibodies |
| JP5960707B2 (ja) * | 2010-10-18 | 2016-08-02 | ネステク ソシエテ アノニム | 抗薬物抗体アイソタイプを決定するための方法 |
| AU2012254150B2 (en) * | 2011-02-17 | 2015-08-13 | Société des Produits Nestlé S.A. | Assays for detecting autoantibodies to anti-TNFalpha drugs |
| KR20140047628A (ko) * | 2011-07-06 | 2014-04-22 | 네스텍 소시에테아노님 | Ｔｎｆ알파로의 생물학적 치료요법에 대한 중화 자가항체의 검출을 위한 검정 |
-
2013
- 2013-11-21 BR BR112015012482A patent/BR112015012482A2/pt not_active IP Right Cessation
- 2013-11-27 HK HK16103834.6A patent/HK1215969A1/zh unknown
- 2013-11-27 AU AU2013350817A patent/AU2013350817A1/en not_active Abandoned
- 2013-11-27 SG SG11201504097PA patent/SG11201504097PA/en unknown
- 2013-11-27 KR KR1020157017311A patent/KR20150088890A/ko not_active Withdrawn
- 2013-11-27 RU RU2015125739A patent/RU2015125739A/ru not_active Application Discontinuation
- 2013-11-27 MX MX2015006852A patent/MX2015006852A/es unknown
- 2013-11-27 JP JP2015544592A patent/JP2016502091A/ja active Pending
- 2013-11-27 WO PCT/IB2013/060458 patent/WO2014083520A2/en not_active Ceased
- 2013-11-27 SG SG10201703210XA patent/SG10201703210XA/en unknown
- 2013-11-27 CA CA2892766A patent/CA2892766A1/en not_active Abandoned
- 2013-11-27 EP EP13820955.6A patent/EP2926136A2/en not_active Withdrawn
- 2013-11-27 CN CN201380071748.4A patent/CN105074461A/zh active Pending
-
2015
- 2015-05-25 IL IL238995A patent/IL238995A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2892766A1 (en) | 2014-06-05 |
| EP2926136A2 (en) | 2015-10-07 |
| AU2013350817A1 (en) | 2015-06-11 |
| WO2014083520A3 (en) | 2014-07-31 |
| SG10201703210XA (en) | 2017-06-29 |
| SG11201504097PA (en) | 2015-06-29 |
| WO2014083520A2 (en) | 2014-06-05 |
| RU2015125739A (ru) | 2017-01-13 |
| JP2016502091A (ja) | 2016-01-21 |
| IL238995A0 (en) | 2015-07-30 |
| KR20150088890A (ko) | 2015-08-03 |
| BR112015012482A2 (pt) | 2017-07-11 |
| HK1215969A1 (zh) | 2016-09-30 |
| CN105074461A (zh) | 2015-11-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2015006852A (es) | Ensayos para detectar autoanticuerpos neutralizantes para terapia biologica. | |
| MX343324B (es) | Ensayos para detectar auto anticuerpos neutralizadores de la terapia biologica con tnf alpha. | |
| MX343327B (es) | Ensayos para detectar autoanticuerpos contra farmacos anti-tnfa. | |
| MX390772B (es) | Métodos para tratar cáncer y el uso de biomarcadores como predictor de sensibilidad clínica a terapias. | |
| AU2018260845A1 (en) | Evaluation and treatment of bradykinin-mediated disorders | |
| BR112014031365A2 (pt) | métodos de detectar doenças ou condições | |
| NZ627443A (en) | Biological markers for identifying patients for treatment with vegf antagonists | |
| MX367046B (es) | Marcadores especificos de via para diagnosticar sindrome del intestino irritable. | |
| BR112014024219A8 (pt) | Métodos de determinação, de otimização da eficácia terapêutica, de monitoramento, de seleção de terapia e de diagnóstico de distúrbio e kit | |
| MX343328B (es) | Analisis para la deteccion de farmacos anti-tnf y anticuerpos. | |
| WO2014153099A3 (en) | Method for using exhaled breath to determine the presence of drug | |
| BR112013006683A2 (pt) | diagnóstico de câncer de mama | |
| BR112015011359A2 (pt) | método para indicar uma presença ou não presença de câncer de próstata agressivo | |
| BR112015001102A2 (pt) | método de detecção de câncer, droga ou kit e método de seleção de droga terapêutica | |
| EP2569635A4 (en) | METHOD FOR DIAGNOSIS AND / OR TREATMENT OF ENZEPHALITIS OR EPILEPSY | |
| WO2011146945A3 (en) | Alk and ros kinase in cancer | |
| SG10201806729VA (en) | Novel assay to detect human periostin | |
| BR112013013457A2 (pt) | métodos para identificar um paciente ou sujeito, para prever a sensibilidade de um sujeito, para identificar sujeitos que têm doença de parkinson e para determinar a resposta do sujeito à terapia e ensaio para seleção de compostos e composições | |
| MX2018011625A (es) | Metodos para detectar bordetella. | |
| WO2011085057A3 (en) | Methods for detecting insulin autoantibody | |
| IN2015MN00140A (enExample) | ||
| MX2021009281A (es) | Metodos de deteccion de legionella. | |
| IN2014KN00742A (enExample) | ||
| HK1205789A1 (en) | Method for selecting or identifying a subject for v1b antagonist therapy | |
| EP2554993A4 (en) | MARKER FOR THE DIAGNOSIS OF THE EFFECT OF ANTICREMULATION |